A Potential Turning Point for Celiac Disease: Teva’s TEV-408 Shows Promise in Phase 2a Trials
By Medical Science Correspondent For millions of individuals living with celiac disease, the current standard of care—a strict, lifelong gluten-free diet—is a demanding and often insufficient solution. Beyond the logistical…
Zaxby’s Appoints Russell Holland as Chief Development Officer to Spearhead Next Phase of Aggressive Expansion
By Industry Desk June 12, 2026 Zaxby’s, the iconic Southern-born chicken chain, has officially solidified its leadership team for the coming decade, announcing the permanent appointment of Russell Holland as…








